Copper, Zinc, and Cu/Zn Ratio in Transitional Cell Carcinoma of the Bladder

被引:38
作者
Golabek, Tomasz [1 ]
Darewicz, Barbara [1 ]
Borawska, Maria [2 ]
Socha, Katarzyna [2 ]
Markiewicz, Renata [2 ]
Kudelski, Jacek [1 ]
机构
[1] Med Univ Bialystok, Dept Urol, PL-15089 Bialystok, Poland
[2] Med Univ Bialystok, Dept Bromatol, PL-15089 Bialystok, Poland
关键词
Bladder cancer; Zinc; Copper; Cu/Zn ratio; TRACE-ELEMENTS; BREAST-CANCER; LUNG-CANCER; DNA-DAMAGE; VITAMIN-A; SERUM; METABOLISM; RISK;
D O I
10.1159/000341976
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Many epidemiological and experimental studies report a strong role of chemical carcinogens in the etiology of bladder cancer. However, involvement of trace elements in the tumorigenesis of transitional cell carcinoma of the bladder has been poorly investigated. The aim of this study was to examine the relationship between zinc, copper and bladder cancer. Materials and Methods: Zinc and copper concentration and Cu/Zn ratio in two 36-sample series of bladder cancer tissue and sera from patients with this neoplasm were matched with those of the control group. The amount of trace elements in every tissue sample was determined using atomic absorption spectrometry. This was correlated with tumor stage. Results: While the copper concentrations reached statistically higher values in the bladder cancer tissue, the zinc levels in the sera and bladder tissue of the patients with this carcinoma were substantially lower as compared to those of the control group. The serum Cu/Zn ratio was significantly higher in the bladder cancer group and this increase was greater in the patients with muscle-invasive neoplasm. Conclusions: The results obtained suggest a relationship between trace elements and the bladder cancer. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:342 / 347
页数:6
相关论文
共 26 条
[1]  
Boz Alper, 2005, Turk J Gastroenterol, V16, P81
[2]   Interactions between zinc and vitamin A: an update [J].
Christian, P ;
West, KP .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (02) :435S-441S
[3]  
DIEZ M, 1989, ONCOLOGY-BASEL, V46, P230
[4]   Tumour vasculature as a target for anticancer therapy [J].
Eatock, MM ;
Schätzlein, A ;
Kaye, SB .
CANCER TREATMENT REVIEWS, 2000, 26 (03) :191-204
[5]  
Golabek T, 2009, SCAND J UROL NEPHROL, V25, P1
[6]   ZINC, COPPER AND OXALOCALCIC UROLITHIASIS [J].
GRASES, F ;
RUIZ, J ;
COSTABAUZA, A ;
COLL, R ;
CONTE, A .
UROLOGIA INTERNATIONALIS, 1993, 50 (04) :205-208
[7]   SERUM TRACE-ELEMENTS AND CU/ZN RATIO IN BREAST-CANCER PATIENTS [J].
GUPTA, SK ;
SHUKLA, VK ;
VAIDYA, MP ;
ROY, SK ;
GUPTA, S .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 46 (03) :178-181
[8]   Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladder [J].
Gupta, SK ;
Singh, SP ;
Shukla, VK .
JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (03) :204-208
[9]   Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma [J].
Han, CZ ;
Jing, JX ;
Zhao, ZW ;
Guo, JG ;
Zheng, SM ;
Du, LL .
BIOLOGICAL TRACE ELEMENT RESEARCH, 2003, 94 (02) :113-122
[10]   Zinc deficiency, DNA damage and cancer risk [J].
Ho, E .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2004, 15 (10) :572-578